News About: Pharm. Industry
Domestic fat-derived stem cell therapy received U.S. FDA approve to progress Phase II clinical trial
Domestic fat-derived stem cell therapy received U.S. FDA approve to progress Phase II clinical trials for the first time
(Yakup Shinmoon)
K-StemCell announced that on Jan 3, 'Jointstem' which is treatment of deg...
High rank domestic pharmaceutical companies are pursuing research and development, but in practice,
High rank domestic pharmaceutical companies are pursuing research and development, but in practice, they are showing signs of focus on the introduction of original drugs
(Yakup Shinmoon)
High rank domestic pharmac...
Consultative group comprised of government, Korea Pharmaceutical Manufacturers Association and civic
Consultative group comprised of government, Korea Pharmaceutical Manufacturers Association and civic group proceeds substantial discussion about Market based Actual Transaction Price with market system analysis report...
Interests are increasing whether two 100-billion-won products in hepatitis B therapeutics market wil
Interests are increasing whether two 100-billion-won products in hepatitis B therapeutics market will come out this year
(Yakup Shinmoon)
Interests are increasing whether two 100-billion-won products in hepatitis ...
Kyowa Hakko Kirin Korea Co. released 'Neulasta’ for the treatment of febrile neutropenia
(Yakup Shinmoon)
Kyowa Hakko Kirin Korea Co. received insurance drug price of 'Neulasta prefilled syringe inj.(nonproprietary name: pegfilgrastim)' which suppresses the expression of 'febrile neutropenia' in patien...
Hanmi Pharm Co. passed the 100 billion won mark in R&D investment for the first time among pharmaceu
Hanmi Pharm Co. passed the 100 billion won mark in R&D investment for the first time among pharmaceutical companies listed on KOSPI
(Yakup Shinmoon)
Hanmi Pharm Co. announced that they passed the 100 billion won m...
It is expected that Yuhan corporation and Green Cross are likely to join the '1 trillion won sales c
(Yakup Shinmoon)
It is expected that Yuhan corporation and Green Cross are likely to join the '1 trillion won sales club' at once for the first time in pharmaceutical industry.
It seems dominant that Yuhan cor...
Introducing the drugs of multinational pharmaceutical company have emerged as a topic
(Yakup Shinmoon)
Export became the conversation topic of this year, due to some large scale exportations made in the beginning of the year.
Meanwhile, to pharmaceutical companies, introducing the drugs of multi...
Boryung Pharmaceutical Co. made $200 million contract including licensing-out contract of 'Kanarb'
(Yakup Shinmoon)
On Jan 9, Boryung Pharmaceutical Co. made a licensing-out contract about new hypertension drug 'Kanarb' with Gloria in China, followed by 13 countries in Latin America including Mexico, Brazil, Rus...
Government and industry-academic organizations identify problems of pharmaceutical pricing and reimb
Government and industry-academic organizations identify problems of pharmaceutical pricing and reimbursement policies
(Yakup Shinmoon)
On Jan 9, Ministry of Health and Welfare had the first meeting with the Korea ...
